Infantile spasms: An overview with focus on therapy;Infantile spasmer

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 15, 2005, Pages 2002-2004

  Rasmussen, Magnhild ^a   Sandvig, Inger ^a   Nustad, Astrid ^b   Skjeldal, Ola H ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOTROPIN; STEROID; TOPIRAMATE; VIGABATRIN; ZONISAMIDE; GLUCOCORTICOID;

CLINICAL PRACTICE; DRUG EFFICACY; DRUG INDICATION; EPILEPSY; HUMAN; INFANT; INFANTILE SPASM; NORWAY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; NEWBORN;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; PROGNOSIS; SPASMS, INFANTILE; VIGABATRIN;

EID: 23844455269     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Wong M, Trevathan E. Infantile spasms. Pediatr Neurol 2001; 24: 89-98.
2. Dulac O. What is West syndrome? Brain Dev 2001; 23: 447-52.
3. Osborne JP, Lux A. Towards an international consensus on definitions and standardised outcome measures for therapeutic trials (and epidemiological studies) in West syndrome. Brain Dev 2001; 23: 677-82.
4. Watanabe K. West syndrome: etiological and prognostic aspects. Brain Dev 1998; 20: 1-8.
5. Stromme P, Mangelsdorf ME, Shaw MA et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002; 30: 441-5.
6. Snead OC. Treatment of infantile spasms. Pediatr Neurol 1990; 6: 147-50.
7. Curatolo P, Verdecchia M, Bombardierei R. Vigabatrin for tuberous sclerosis complex. Brain Dev 2001; 23: 649-53.
8. Mackay M, Weiss S, Snead OC 3rd. Treatment of infantile spasms: an evidence-based approach. Int Rev Neurobiol 2002; 49: 157-84.
9. Wallace S. Newer antiepileptic drugs: advantages and disadvantages. Brain Dev 2001; 23: 277-83.
10. Cossette P, Riviello JJ, Carmant L. ACTH versus vigabatrin therapy in infantile spasms: A retrospective study. Neurology 1999; 52: 1691-4.
11. Iannetti P, Spalice A, Perla FM et al. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics 2000; 106: 838-42.
12. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997; 314: 180.
13. Riikonen R. West's syndrome. I: Wallace S, red. Epilepsy in children. London: Chapman & Hall, 1996: 209-25.
14. 6 treatment in West syndrome. Brain Dev 2001; 23: 654-7.
15. Suzuki Y. Zonisamide in West syndrome. Brain Dev 2001; 23: 658-61.
16. Mikaeloff Y, deSaint-Martin A, Mancini J et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003; 53: 225-32.
17. Asano E, Chugani DC, Juhasz C et al. Surgical treatment of West syndrome. Brain Dev 2001; 23: 668-76.
18. Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev 2001; 23: 683-7.
19. Hancock E, Osborne J, Milner P. Treatment of infantile spasms. Cochrane Database Syst Rev 2003; 3: CD001770.
20. Riikonen R. ACTH therapy of West syndrome: Finnish views. Brain Dev 2001; 23: 642-6.
21. Zupanc ML. Infantile spasms. Expert Opin Pharmacother 2003; 4: 2039-48.
22. Appleton RE. West syndrome: long-term prognosis and social aspects. Brain Dev 2001; 23: 688-91.
23. Eisermann MM, DeLaRaillere A, Dellatolas G et al. Infantile spasms in Down syndrome - effects of delayed anticonvulsive treament. Epilepsy Res 2003; 55: 21-7.
24. Ito M. Extremely low-dose ACTH therapy for West syndrome in Japan. Brain Dev 2001; 23: 635-41.
25. Nustad A. Infantile spasmer. I: Grøgaard J, Winsnes A, Carlsen K-H et al, red. Veileder i akutt pediatri. Oslo: Norsk barnelegeforening, 1998: 166-7.
26. Lux A, Edwards S, Hancock E et al. The United Kingdom infantile spasm study: outcomes at day 14. Abstrakt. Eur J Paediatr Neurol 2003; 7: 346.